Loading data for GRI — first visit, this takes a few seconds.
GRI Bio Inc. (GRI)
NasdaqCM: GRI
· 실시간 가격 · USD
1.73
+0.06 (3.59%)
종가 기준: Aug 19, 2026, 8:00 PM
1.76
+1.73%
애프터마켓: 4:17 PM
GRI Bio Inc. (GRI) Stock Price, Analysis & Data
3.59% (1D)
데이터 없음
GRI 소개
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. Th...
전체 기업 정보
